Compound information
- Natural Products
- ZC1072969
- Molecular Formula
- C9H8BrNO
- Molecular Weight
- 224.978925976 g/mol
- Structure
-
- IUPAC Name
- N-(4-bromophenyl)prop-2-enamide
- InChI
- InChI=1S/C9H8BrNO/c1-2-9(12)11-8-5-3-7(10)4-6-8/h2-6H,1H2,(H,11,12)
- InChI Key
- ZSBLNRQSHLZWNV-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1ccc(Br)cc1
- Source
- ZINC000000454029
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 12 | Ring Count | 1 |
Heteroatom Count | 3 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 1 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 29.1 Å2 | LogP | 2.934 |
LogS | -3.187 | LogD | 2.849 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.047 | Pgp substrate | 0.874 |
HIA | 0.962 | F20 % | 0.992 |
F30 % | 0.895 | Caco-2 | -4.384 |
MDCK | -4.658 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.981 | PPB | 94.148 |
VD | 0.37 | Fu | 1.413 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.999 | CYP1A2 substrate | 0.73 |
CYP2A6 substrate | 0.735 | CYP2B6 substrate | 0.521 |
CYP2C19 inhibitor | 0.736 | CYP2C19 substrate | 0.769 |
CYP2C8 substrate | 0.797 | CYP2C9 inhibitor | 0.058 |
CYP2C9 substrate | 0.379 | CYP2D6 inhibitor | 0.041 |
CYP2D6 substrate | 0.819 | CYP2E1 substrate | 0.969 |
CYP3A4 inhibitor | 0.006 | CYP3A4 substrate | 0.802 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.338 | CL | 8.362 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.005 | Hepatotoxicity | 0.998 |
Mutagenicity | 0.0 | Rat Oral Acute Toxicity | 0.199 |
FDAMDD | 0.364 | Skin Sensitization | 0.989 |
Carcinogenicity | 0.293 | Eye Corrosion | 0.995 |
Eye Irritation | 0.945 | Respiratory Toxicity | 0.155 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.942 | IGC50 | 3.808 |
LC50FM | 4.612 | LC50DM | 5.381 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.12 | NR-AR-LBD | 0.236 |
NR-AhR | 0.722 | NR-Aromatase | 0.078 |
NR-ER | 0.451 | NR-ER-LBD | 0.424 |
NR-PPAR-gamma | 0.8 | SR-ARE | 0.865 |
SR-ATAD5 | 0.598 | SR-HSE | 0.315 |
SR-MMP | 0.507 | SR-p53 | 0.733 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.